Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes
Open Access
- 4 October 2006
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 5 (1) , 21
Abstract
Background Patients with diabetes already fulfill one diagnostic criterion for MS according to the existing classifications. Our aim was to identify one single clinical parameter, which could effectively predict the presence of MS in patients with type 2 diabetes. Methods We studied all patients with type 2 diabetes who attended our Diabetes Outpatient Clinic during a three-month period. Waist circumference, blood pressure and serum lipids were measured. Establishment of MS diagnosis was based a) on National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria and b) on International Diabetes Federation (IDF) criteria. Receiver operating characteristic (ROC) analysis was applied in order to identify the clinical parameter with the highest predictive capability for MS. Among the 500 participating patients (231 males, 269 females), MS was diagnosed in 364 patients (72.8%) according to the NCEP ATP III criteria and in 408 patients (81.6%) according to the IDF criteria. Results For the NCEP ATP III classification, serum triglycerides (in the overall population), waist and HDL (in female population) demonstrated the highest predictive capability for MS (AUCs:0.786, 0.805 and 0.801, respectively). For the IDF classification, no single parameter reached an AUC > 0.800 in the overall population. In females, HDL displayed a satisfactory predictive capability for MS with an AUC which was significantly higher than the one in males (0.785 vs. 0.676, respectively, p < 0.05). Conclusion Elevated serum triglycerides strongly indicate the presence of MS in patients with type 2 diabetes. In female patients with type 2 diabetes, central obesity was the second stronger predictor of MS besides hypertriglyceridemia.Keywords
This publication has 15 references indexed in Scilit:
- Clinical Implications of Nonopioid Analgesia for Relief of Mild-to-Moderate Pain in Patients with or at Risk for Cardiovascular DiseaseThe American Journal of Cardiology, 2006
- Trend in the Prevalence of the Metabolic Syndrome and Its Impact on Cardiovascular Disease IncidenceDiabetes Care, 2006
- The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular DiseaseThe American Journal of Cardiology, 2006
- Introduction to the metabolic syndromeEuropean Heart Journal Supplements, 2005
- Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 DiabetesDiabetes Care, 2004
- The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications StudyDiabetic Medicine, 2003
- Identification of Subjects with Insulin Resistance and β-Cell Dysfunction Using Alternative Definitions of the Metabolic SyndromeDiabetes, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982